APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mesalazine

This report study Mesalamine API market, Mesalamine API is off white to creamish colored powder. Mesalazine was approved for medical use in the United States in 1987.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

This report study Mesalamine API market, Mesalamine API is off white to creamish colored powder. Mesalazine was approved for medical use in the United States in 1987.

Mesalazine also known as mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.

Selected research

Market Structure

Global Mesalazine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

31 December 2025193 pages

Choose your research edition.

Industry ResearchMesalazine Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Mesalazine Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Mesalazine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mesalazine Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Mesalazine Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

This report study Mesalamine API market, Mesalamine API is off white to creamish colored powder. Mesalazine was approved for medical use in the United States in 1987.

Mesalazine also known as mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.

The industry's leading manufacturers are Syntese A/S, PharmaZell and Cambrex Corporation etc. The top 3 companies hold a share over 50%. In terms of regions, the revenue share in Europe is the highest, reaching 43% in 2021, followed by Asia Pacific with a share about 31%.

Read the full market overview

This report provides an overview of the global Mesalazine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Mesalazine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Mesalazine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Mesalazine market size, projected growth trends, production technologies, key applications, and end-use industries.

Mesalazine Segment by Company

PharmaZell

Syntese A/S

Cambrex Corporation

Divis Laboratories

Chemi SpA

Ipca Laboratories

Hangzhou Brother

Lianyungang Fengheng Biopharm

Lasa Loboratory

Corden Pharma Bergamo

Erregierre SpA

CTX Lifescience

Ishita Active Pharma Ingredients

YC Biotech (Jiangsu)

Xinxiang Tianfeng Fine Chemical

Mesalazine Segment by Purity

Above 97 %

Above 98 %

Above 99 %

Mesalazine Segment by Application

Tablets

Capsules

Pellet and Granule

Suppository

Enema

Others

Mesalazine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mesalazine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mesalazine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mesalazine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Mesalazine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Mesalazine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Mesalazine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Mesalazine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Mesalazine Industry Trends Table 2. Mesalazine Industry Drivers Table 3. Mesalazine Industry Opportunities and Challenges Table 4. Mesalazine Industry Restraints Table 5. Global Mesalazine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Mesalazine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Mesalazine Sales by Manufacturers (Ton) & (2021-2026) Table 8. Global Mesalazine Sales Market Share by Manufacturers Table 9. Global Mesalazine Average Sales Price (US$/Kg) of Manufacturers (2021-2026) Table 10. Global Mesalazine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Mesalazine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Mesalazine Manufacturers, Product Type & Application Table 13. Global Mesalazine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Mesalazine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Above 97 % Table 17. Major Manufacturers of Above 98 % Table 18. Major Manufacturers of Above 99 % Table 19. Global Mesalazine Sales by Type 2021 VS 2025 VS 2032 (Ton) Table 20. Global Mesalazine Sales by Type (2021-2026) & (Ton) Table 21. Global Mesalazine Sales by Type (2027-2032) & (Ton) Table 22. Global Mesalazine Sales Market Share by Type (2021-2026) Table 23. Global Mesalazine Sales Market Share by Type (2027-2032) Table 24. Global Mesalazine Revenue by Type 2021 VS 2025 VS 2032 (Ton) Table 25. Global Mesalazine Revenue by Type (2021-2026) & (Ton) Table 26. Global Mesalazine Revenue by Type (2027-2032) & (Ton) Table 27. Global Mesalazine Revenue Market Share by Type (2021-2026) Table 28. Global Mesalazine Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Tablets Table 30. Major Manufacturers of Capsules Table 31. Major Manufacturers of Pellet and Granule Table 32. Major Manufacturers of Suppository Table 33. Major Manufacturers of Enema Table 34. Major Manufacturers of Others Table 35. Global Mesalazine Sales by Application 2021 VS 2025 VS 2032 (Ton) Table 36. Global Mesalazine Sales by Application (2021-2026) & (Ton) Table 37. Global Mesalazine Sales by Application (2027-2032) & (Ton) Table 38. Global Mesalazine Sales Market Share by Application (2021-2026) Table 39. Global Mesalazine Sales Market Share by Application (2027-2032) Table 40. Global Mesalazine Revenue by Application 2021 VS 2025 VS 2032 (Ton) Table 41. Global Mesalazine Revenue by Application (2021-2026) & (Ton) Table 42. Global Mesalazine Revenue by Application (2027-2032) & (Ton) Table 43. Global Mesalazine Revenue Market Share by Application (2021-2026) Table 44. Global Mesalazine Revenue Market Share by Application (2027-2032) Table 45. Global Mesalazine Sales by Region: 2021 VS 2025 VS 2032 (Ton) Table 46. Global Mesalazine Sales by Region (2021-2026) & (Ton) Table 47. Global Mesalazine Sales Market Share by Region (2021-2026) Table 48. Global Mesalazine Sales Forecasted by Region (2027-2032) & (Ton) Table 49. Global Mesalazine Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Mesalazine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Ton) Table 51. North America Mesalazine Sales by Country (2021-2026) & (Ton) Table 52. North America Mesalazine Sales by Country (2027-2032) & (Ton) Table 53. Europe Mesalazine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Ton) Table 54. Europe Mesalazine Sales by Country (2021-2026) & (Ton) Table 55. Europe Mesalazine Sales by Country (2027-2032) & (Ton) Table 56. Asia Pacific Mesalazine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Ton) Table 57. Asia Pacific Mesalazine Sales by Country (2021-2026) & (Ton) Table 58. Asia Pacific Mesalazine Sales by Country (2027-2032) & (Ton) Table 59. South America, Middle East and Africa Mesalazine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Ton) Table 60. South America, Middle East and Africa Mesalazine Sales by Country (2021-2026) & (Ton) Table 61. South America, Middle East and Africa Mesalazine Sales by Country (2027-2032) & (Ton) Table 62. Global Mesalazine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Mesalazine Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Mesalazine Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Mesalazine Revenue Market Share by Region (2021-2026) Table 66. Global Mesalazine Revenue Market Share by Region (2027-2032) Table 67. PharmaZell Company Information Table 68. PharmaZell Business Overview Table 69. PharmaZell Mesalazine Sales (Ton), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. PharmaZell Mesalazine Product Portfolio Table 71. PharmaZell Recent Development Table 72. Syntese A/S Company Information Table 73. Syntese A/S Business Overview Table 74. Syntese A/S Mesalazine Sales (Ton), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Syntese A/S Mesalazine Product Portfolio Table 76. Syntese A/S Recent Development Table 77. Cambrex Corporation Company Information Table 78. Cambrex Corporation Business Overview Table 79. Cambrex Corporation Mesalazine Sales (Ton), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Cambrex Corporation Mesalazine Product Portfolio Table 81. Cambrex Corporation Recent Development Table 82. Divis Laboratories Company Information Table 83. Divis Laboratories Business Overview Table 84. Divis Laboratories Mesalazine Sales (Ton), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Divis Laboratories Mesalazine Product Portfolio Table 86. Divis Laboratories Recent Development Table 87. Chemi SpA Company Information Table 88. Chemi SpA Business Overview Table 89. Chemi SpA Mesalazine Sales (Ton), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Chemi SpA Mesalazine Product Portfolio Table 91. Chemi SpA Recent Development Table 92. Ipca Laboratories Company Information Table 93. Ipca Laboratories Business Overview Table 94. Ipca Laboratories Mesalazine Sales (Ton), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Ipca Laboratories Mesalazine Product Portfolio Table 96. Ipca Laboratories Recent Development Table 97. Hangzhou Brother Company Information Table 98. Hangzhou Brother Business Overview Table 99. Hangzhou Brother Mesalazine Sales (Ton), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Hangzhou Brother Mesalazine Product Portfolio Table 101. Hangzhou Brother Recent Development Table 102. Lianyungang Fengheng Biopharm Company Information Table 103. Lianyungang Fengheng Biopharm Business Overview Table 104. Lianyungang Fengheng Biopharm Mesalazine Sales (Ton), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Lianyungang Fengheng Biopharm Mesalazine Product Portfolio Table 106. Lianyungang Fengheng Biopharm Recent Development Table 107. Lasa Loboratory Company Information Table 108. Lasa Loboratory Business Overview Table 109. Lasa Loboratory Mesalazine Sales (Ton), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Lasa Loboratory Mesalazine Product Portfolio Table 111. Lasa Loboratory Recent Development Table 112. Corden Pharma Bergamo Company Information Table 113. Corden Pharma Bergamo Business Overview Table 114. Corden Pharma Bergamo Mesalazine Sales (Ton), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Corden Pharma Bergamo Mesalazine Product Portfolio Table 116. Corden Pharma Bergamo Recent Development Table 117. Erregierre SpA Company Information Table 118. Erregierre SpA Business Overview Table 119. Erregierre SpA Mesalazine Sales (Ton), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Erregierre SpA Mesalazine Product Portfolio Table 121. Erregierre SpA Recent Development Table 122. CTX Lifescience Company Information Table 123. CTX Lifescience Business Overview Table 124. CTX Lifescience Mesalazine Sales (Ton), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. CTX Lifescience Mesalazine Product Portfolio Table 126. CTX Lifescience Recent Development Table 127. Ishita Active Pharma Ingredients Company Information Table 128. Ishita Active Pharma Ingredients Business Overview Table 129. Ishita Active Pharma Ingredients Mesalazine Sales (Ton), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Ishita Active Pharma Ingredients Mesalazine Product Portfolio Table 131. Ishita Active Pharma Ingredients Recent Development Table 132. YC Biotech (Jiangsu) Company Information Table 133. YC Biotech (Jiangsu) Business Overview Table 134. YC Biotech (Jiangsu) Mesalazine Sales (Ton), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. YC Biotech (Jiangsu) Mesalazine Product Portfolio Table 136. YC Biotech (Jiangsu) Recent Development Table 137. Xinxiang Tianfeng Fine Chemical Company Information Table 138. Xinxiang Tianfeng Fine Chemical Business Overview Table 139. Xinxiang Tianfeng Fine Chemical Mesalazine Sales (Ton), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 140. Xinxiang Tianfeng Fine Chemical Mesalazine Product Portfolio Table 141. Xinxiang Tianfeng Fine Chemical Recent Development Table 142. Key Raw Materials Table 143. Raw Materials Key Suppliers Table 144. Mesalazine Distributors List Table 145. Mesalazine Customers List Table 146. Research Programs/Design for This Report Table 147. Authors List of This Report Table 148. Secondary Sources Table 149. Primary Sources List of Figures Figure 1. Mesalazine Product Image Figure 2. Global Mesalazine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mesalazine Market Size (2021-2032) & (US$ Million) Figure 4. Global Mesalazine Sales (2021-2032) & (Ton) Figure 5. Global Mesalazine Average Price (US$/Kg) & (2021-2032) Figure 6. Global Top 5 and 10 Mesalazine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Above 97 % Image Figure 9. Above 98 % Image Figure 10. Above 99 % Image Figure 11. Global Mesalazine Sales by Type (2021 VS 2025 VS 2032) & (Ton) Figure 12. Global Mesalazine Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Mesalazine Sales Market Share by Type (2021-2032) Figure 14. Global Mesalazine Revenue by Type (2021 VS 2025 VS 2032) & (Ton) Figure 15. Global Mesalazine Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Mesalazine Revenue Market Share by Type (2021-2032) Figure 17. Tablets Image Figure 18. Capsules Image Figure 19. Pellet and Granule Image Figure 20. Suppository Image Figure 21. Enema Image Figure 22. Others Image Figure 23. Global Mesalazine Sales by Application (2021 VS 2025 VS 2032) & (Ton) Figure 24. Global Mesalazine Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Mesalazine Sales Market Share by Application (2021-2032) Figure 26. Global Mesalazine Revenue by Application (2021 VS 2025 VS 2032) & (Ton) Figure 27. Global Mesalazine Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Mesalazine Revenue Market Share by Application (2021-2032) Figure 29. North America Mesalazine Sales and Growth Rate (2021-2032) & (Ton) Figure 30. North America Mesalazine Sales Market Share by Country (2021-2032) Figure 31. U.S. Mesalazine Sales and Growth Rate (2021-2032) & (Ton) Figure 32. Canada Mesalazine Sales and Growth Rate (2021-2032) & (Ton) Figure 33. Mexico Mesalazine Sales and Growth Rate (2021-2032) & (Ton) Figure 34. Europe Mesalazine Sales and Growth Rate (2021-2032) & (Ton) Figure 35. Europe Mesalazine Sales Market Share by Country (2021-2032) Figure 36. Germany Mesalazine Sales and Growth Rate (2021-2032) & (Ton) Figure 37. France Mesalazine Sales and Growth Rate (2021-2032) & (Ton) Figure 38. U.K. Mesalazine Sales and Growth Rate (2021-2032) & (Ton) Figure 39. Italy Mesalazine Sales and Growth Rate (2021-2032) & (Ton) Figure 40. Netherlands Mesalazine Sales and Growth Rate (2021-2032) & (Ton) Figure 41. Asia Pacific Mesalazine Sales and Growth Rate (2021-2032) & (Ton) Figure 42. Asia Pacific Mesalazine Sales Market Share by Country (2021-2032) Figure 43. China Mesalazine Sales and Growth Rate (2021-2032) & (Ton) Figure 44. Japan Mesalazine Sales and Growth Rate (2021-2032) & (Ton) Figure 45. South Korea Mesalazine Sales and Growth Rate (2021-2032) & (Ton) Figure 46. Southeast Asia Mesalazine Sales and Growth Rate (2021-2032) & (Ton) Figure 47. India Mesalazine Sales and Growth Rate (2021-2032) & (Ton) Figure 48. Australia Mesalazine Sales and Growth Rate (2021-2032) & (Ton) Figure 49. South America, Middle East and Africa Mesalazine Sales and Growth Rate (2021-2032) & (Ton) Figure 50. South America, Middle East and Africa Mesalazine Sales Market Share by Country (2021-2032) Figure 51. Brazil Mesalazine Sales and Growth Rate (2021-2032) & (Ton) Figure 52. South Africa Mesalazine Sales and Growth Rate (2021-2032) & (Ton) Figure 53. Saudi Arabia Mesalazine Sales and Growth Rate (2021-2032) & (Ton) Figure 54. Turkey Mesalazine Sales and Growth Rate (2021-2032) & (Ton) Figure 55. Argentina Mesalazine Sales and Growth Rate (2021-2032) & (Ton) Figure 56. UAE Mesalazine Sales and Growth Rate (2021-2032) & (Ton) Figure 57. Egypt Mesalazine Sales and Growth Rate (2021-2032) & (Ton) Figure 58. Chile Mesalazine Sales and Growth Rate (2021-2032) & (Ton) Figure 59. Global Mesalazine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Mesalazine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Mesalazine Revenue (2021-2032) & (US$ Million) Figure 62. North America Mesalazine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Mesalazine Revenue (2021-2032) & (US$ Million) Figure 64. Europe Mesalazine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Mesalazine Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Mesalazine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Mesalazine Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Mesalazine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Mesalazine Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Mesalazine Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Above 97 %
  • Above 98 %
  • Above 99 %
Applications
  • Tablets
  • Capsules
  • Pellet and Granule
  • Suppository
  • Enema
  • Others
Companies covered
  • PharmaZell
  • Syntese A/S
  • Cambrex Corporation
  • Divis Laboratories
  • Chemi SpA
  • Ipca Laboratories
  • Hangzhou Brother
  • Lianyungang Fengheng Biopharm
  • Lasa Loboratory
  • Corden Pharma Bergamo
  • Erregierre SpA
  • CTX Lifescience
  • Ishita Active Pharma Ingredients
  • YC Biotech (Jiangsu)
  • Xinxiang Tianfeng Fine Chemical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Mesalazine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Mesalazine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Mesalazine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Mesalazine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Mesalazine Market Dynamics
  1. 2.1 Mesalazine Industry Trends
  2. 2.2 Mesalazine Industry Drivers
  3. 2.3 Mesalazine Industry Opportunities and Challenges
  4. 2.4 Mesalazine Industry Restraints
3 Mesalazine Market by Manufacturers
  1. 3.1 Global Mesalazine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Mesalazine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Mesalazine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Mesalazine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Mesalazine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Mesalazine Manufacturers, Product Type & Application
  7. 3.7 Global Mesalazine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Mesalazine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Mesalazine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Mesalazine Tier 1, Tier 2, and Tier 3
4 Mesalazine Market by Type
  1. 4.1 Mesalazine Type Introduction
  2. 4.1.1 Above 97 %
  3. 4.1.2 Above 98 %
  4. 4.1.3 Above 99 %
  5. 4.2 Global Mesalazine Sales by Type
  6. 4.2.1 Global Mesalazine Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Mesalazine Sales by Type (2021-2032)
  8. 4.2.3 Global Mesalazine Sales Market Share by Type (2021-2032)
  9. 4.3 Global Mesalazine Revenue by Type
  10. 4.3.1 Global Mesalazine Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Mesalazine Revenue by Type (2021-2032)
  12. 4.3.3 Global Mesalazine Revenue Market Share by Type (2021-2032)
5 Mesalazine Market by Application
  1. 5.1 Mesalazine Application Introduction
  2. 5.1.1 Tablets
  3. 5.1.2 Capsules
  4. 5.1.3 Pellet and Granule
  5. 5.1.4 Suppository
  6. 5.1.5 Enema
  7. 5.1.6 Others
  8. 5.2 Global Mesalazine Sales by Application
  9. 5.2.1 Global Mesalazine Sales by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Mesalazine Sales by Application (2021-2032)
  11. 5.2.3 Global Mesalazine Sales Market Share by Application (2021-2032)
  12. 5.3 Global Mesalazine Revenue by Application
  13. 5.3.1 Global Mesalazine Revenue by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global Mesalazine Revenue by Application (2021-2032)
  15. 5.3.3 Global Mesalazine Revenue Market Share by Application (2021-2032)
6 Global Mesalazine Sales by Region
  1. 6.1 Global Mesalazine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Mesalazine Sales by Region (2021-2032)
  3. 6.2.1 Global Mesalazine Sales by Region (2021-2026)
  4. 6.2.2 Global Mesalazine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Mesalazine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Mesalazine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Mesalazine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Mesalazine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Mesalazine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Mesalazine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Mesalazine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Mesalazine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Mesalazine Revenue by Region
  1. 7.1 Global Mesalazine Revenue by Region
  2. 7.1.1 Global Mesalazine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Mesalazine Revenue by Region (2021-2026)
  4. 7.1.3 Global Mesalazine Revenue by Region (2027-2032)
  5. 7.1.4 Global Mesalazine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Mesalazine Revenue (2021-2032)
  8. 7.2.2 North America Mesalazine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Mesalazine Revenue (2021-2032)
  11. 7.3.2 Europe Mesalazine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Mesalazine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Mesalazine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Mesalazine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Mesalazine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 PharmaZell
  2. 8.1.1 PharmaZell Company Information
  3. 8.1.2 PharmaZell Business Overview
  4. 8.1.3 PharmaZell Mesalazine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 PharmaZell Mesalazine Product Portfolio
  6. 8.1.5 PharmaZell Recent Developments
  7. 8.2 Syntese A/S
  8. 8.2.1 Syntese A/S Company Information
  9. 8.2.2 Syntese A/S Business Overview
  10. 8.2.3 Syntese A/S Mesalazine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Syntese A/S Mesalazine Product Portfolio
  12. 8.2.5 Syntese A/S Recent Developments
  13. 8.3 Cambrex Corporation
  14. 8.3.1 Cambrex Corporation Company Information
  15. 8.3.2 Cambrex Corporation Business Overview
  16. 8.3.3 Cambrex Corporation Mesalazine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Cambrex Corporation Mesalazine Product Portfolio
  18. 8.3.5 Cambrex Corporation Recent Developments
  19. 8.4 Divis Laboratories
  20. 8.4.1 Divis Laboratories Company Information
  21. 8.4.2 Divis Laboratories Business Overview
  22. 8.4.3 Divis Laboratories Mesalazine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Divis Laboratories Mesalazine Product Portfolio
  24. 8.4.5 Divis Laboratories Recent Developments
  25. 8.5 Chemi SpA
  26. 8.5.1 Chemi SpA Company Information
  27. 8.5.2 Chemi SpA Business Overview
  28. 8.5.3 Chemi SpA Mesalazine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Chemi SpA Mesalazine Product Portfolio
  30. 8.5.5 Chemi SpA Recent Developments
  31. 8.6 Ipca Laboratories
  32. 8.6.1 Ipca Laboratories Company Information
  33. 8.6.2 Ipca Laboratories Business Overview
  34. 8.6.3 Ipca Laboratories Mesalazine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Ipca Laboratories Mesalazine Product Portfolio
  36. 8.6.5 Ipca Laboratories Recent Developments
  37. 8.7 Hangzhou Brother
  38. 8.7.1 Hangzhou Brother Company Information
  39. 8.7.2 Hangzhou Brother Business Overview
  40. 8.7.3 Hangzhou Brother Mesalazine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Hangzhou Brother Mesalazine Product Portfolio
  42. 8.7.5 Hangzhou Brother Recent Developments
  43. 8.8 Lianyungang Fengheng Biopharm
  44. 8.8.1 Lianyungang Fengheng Biopharm Company Information
  45. 8.8.2 Lianyungang Fengheng Biopharm Business Overview
  46. 8.8.3 Lianyungang Fengheng Biopharm Mesalazine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Lianyungang Fengheng Biopharm Mesalazine Product Portfolio
  48. 8.8.5 Lianyungang Fengheng Biopharm Recent Developments
  49. 8.9 Lasa Loboratory
  50. 8.9.1 Lasa Loboratory Company Information
  51. 8.9.2 Lasa Loboratory Business Overview
  52. 8.9.3 Lasa Loboratory Mesalazine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Lasa Loboratory Mesalazine Product Portfolio
  54. 8.9.5 Lasa Loboratory Recent Developments
  55. 8.10 Corden Pharma Bergamo
  56. 8.10.1 Corden Pharma Bergamo Company Information
  57. 8.10.2 Corden Pharma Bergamo Business Overview
  58. 8.10.3 Corden Pharma Bergamo Mesalazine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Corden Pharma Bergamo Mesalazine Product Portfolio
  60. 8.10.5 Corden Pharma Bergamo Recent Developments
  61. 8.11 Erregierre SpA
  62. 8.11.1 Erregierre SpA Company Information
  63. 8.11.2 Erregierre SpA Business Overview
  64. 8.11.3 Erregierre SpA Mesalazine Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Erregierre SpA Mesalazine Product Portfolio
  66. 8.11.5 Erregierre SpA Recent Developments
  67. 8.12 CTX Lifescience
  68. 8.12.1 CTX Lifescience Company Information
  69. 8.12.2 CTX Lifescience Business Overview
  70. 8.12.3 CTX Lifescience Mesalazine Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 CTX Lifescience Mesalazine Product Portfolio
  72. 8.12.5 CTX Lifescience Recent Developments
  73. 8.13 Ishita Active Pharma Ingredients
  74. 8.13.1 Ishita Active Pharma Ingredients Company Information
  75. 8.13.2 Ishita Active Pharma Ingredients Business Overview
  76. 8.13.3 Ishita Active Pharma Ingredients Mesalazine Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Ishita Active Pharma Ingredients Mesalazine Product Portfolio
  78. 8.13.5 Ishita Active Pharma Ingredients Recent Developments
  79. 8.14 YC Biotech (Jiangsu)
  80. 8.14.1 YC Biotech (Jiangsu) Company Information
  81. 8.14.2 YC Biotech (Jiangsu) Business Overview
  82. 8.14.3 YC Biotech (Jiangsu) Mesalazine Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 YC Biotech (Jiangsu) Mesalazine Product Portfolio
  84. 8.14.5 YC Biotech (Jiangsu) Recent Developments
  85. 8.15 Xinxiang Tianfeng Fine Chemical
  86. 8.15.1 Xinxiang Tianfeng Fine Chemical Company Information
  87. 8.15.2 Xinxiang Tianfeng Fine Chemical Business Overview
  88. 8.15.3 Xinxiang Tianfeng Fine Chemical Mesalazine Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Xinxiang Tianfeng Fine Chemical Mesalazine Product Portfolio
  90. 8.15.5 Xinxiang Tianfeng Fine Chemical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Mesalazine Value Chain Analysis
  2. 9.1.1 Mesalazine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Mesalazine Production Mode & Process
  6. 9.2 Mesalazine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Mesalazine Distributors
  9. 9.2.3 Mesalazine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst